Histamine alters E-cadherin cell adhesion to increase human airway epithelial permeability.
During the immediate response to an inhaled allergen, there is an increase in the paracellular permeability of the airway epithelium.1 Histamine is an important agonist released during the immediate response to inhaled allergen. We hypothesized that histamine would increase human airway epithelial paracellular permeability and that it would do this by interrupting E-cadherin-based cell adhesion. Histamine, applied to the basolateral surface, increased the paracellular permeability of cultured human airway epithelia, and this effect of histamine was blocked by the histamine receptor antagonist promethazine. ECV304 cells express a histamine receptor, N-cadherin, and elements of the tight junction, including claudins, but they do not express E-cadherin. Histamine increased the paracellular permeability of ECV304 cells transfected with a vector and expressing E-cadherin but not ECV304 cells expressing lac-Z in the same vector. L cells do not express the histamine receptor, cadherins, or claudins. Histamine decreased adhesion of L cells expressing the human histamine receptor and E-cadherin to an E-cadherin-Fc fusion protein. Histamine did not alter the adhesion to the E-cadherin fusion protein of L cells expressing either the histamine receptor or E-cadherin alone. When applied to the apical surface, adenovirus poorly infects airway epithelial cells because its receptor, CAR, is restricted to the basolateral surface of the cells. When histamine was applied to the basolateral surface of airway epithelial cells, infection of the cells by adenovirus increased by approximately one log. This effect of histamine was also blocked by promethazine. Histamine increases airway paracellular permeability and increases susceptibility of airway epithelial cells to infection by adenovirus by interrupting E-cadherin adhesion.
Zabner
Joseph
J
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242, USA.
Winter
Michael
M
Excoffon
Katherine J D Ashbourne
KJ
Stoltz
David
D
Ries
Dana
D
Shasby
Sandra
S
Shasby
Michael
M
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D015820:Cadherins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D002448:Cell Adhesion / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D002463:Cell Membrane Permeability / Q000187:drug effects; D018076:DNA, Complementary / Q000096:biosynthesis; D003907:Dexamethasone / Q000494:pharmacology; D004847:Epithelial Cells / Q000187:drug effects*; D049452:Green Fluorescent Proteins; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007739:L Cells; D008164:Luminescent Proteins / Q000235:genetics; D051379:Mice; D010957:Plasmids / Q000235:genetics; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D011968:Receptors, Histamine / Q000235:genetics / Q000378:metabolism; D011991:Receptors, Virus / Q000235:genetics; D012137:Respiratory System / Q000166:cytology* / Q000187:drug effects; D014162:Transfection; D001616:beta-Galactosidase / Q000378:metabolism
D015820:Cadherins; D018076:DNA, Complementary; D008164:Luminescent Proteins; D012333:RNA, Messenger; D011968:Receptors, Histamine; D011991:Receptors, Virus; D049452:Green Fluorescent Proteins; D003907:Dexamethasone; D006632:Histamine; D001616:beta-Galactosidase